{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:48:04Z","timestamp":1768528084794,"version":"3.49.0"},"posted":{"date-parts":[[2025,11,25]]},"group-title":"Microbiology","reference-count":102,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"name":"NIH\/NIAID grants","award":["AI125626 and AI128556"],"award-info":[{"award-number":["AI125626 and AI128556"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,11,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Mammarenaviruses (MaAv) cause persistent infection in their natural rodent hosts across the world and via zoonotic events can cause severe disease in humans. Thus, the MaAv Lassa virus (LASV) in Western Africa and Junin virus (JUNV) in the Argentinean Pampas cause hemorrhagic fever diseases with significant case fatality rates in their endemic regions. In addition, the globally distributed MaAv lymphocytic choriomeningitis virus (LCMV) is an underrecognized human pathogen of clinical significance capable of causing devastating infections in neonates and immunocompromised individuals. Despite their impact on human health, there are currently no FDA-approved vaccines or specific antiviral treatments for MaAv infections. Existing anti-MaAv therapies are limited to the off-label use of ribavirin whose efficacy remains controversial, hence, the significance of developing novel therapeutics to combat human pathogenic MaAv. We employed a high-throughput cell-based infection assay to screen the Pandemic Response Box, a collection of 400 diverse compounds with established antimicrobial activity, for MaAv inhibitors. We identified Ro-24-7429, an antagonist of the HIV-1 Tat protein and RUNX Family Transcription Factor 1 inhibitor; WO 2006118607 A2, a dihydroorotate dehydrogenase inhibitor; and verdinexor, a novel selective inhibitor of nuclear export (SINE) targeting the CRM1\/XPO1, as potent anti-MaAv compounds. Consistent with their distinct validated targets, verdinexor and WO 2006118607 A2 exhibited a very strong synergistic antiviral activity when used in combination therapy. Our findings pave the way for the development of verdinexor as a potent host-directed antiviral against MaAv, which could be integrated into the development of combination therapy with direct-or host-acting antivirals to combat human pathogenic MaAv.<\/jats:p>","DOI":"10.1101\/2025.11.24.690217","type":"posted-content","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:30:14Z","timestamp":1764117014000},"source":"Crossref","is-referenced-by-count":0,"title":["Pandemic Response Box Screening Identified CRM1\/XPO1 as an Anti-Mammarenavirus Druggable Target"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0664-9698","authenticated-orcid":false,"given":"Chukwudi A.","family":"Ofodile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8048-410X","authenticated-orcid":false,"given":"Beatrice","family":"Cubitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngozi","family":"Onyemelukwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4125-7155","authenticated-orcid":false,"given":"Chetachi B.","family":"Okwuanaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0174-8454","authenticated-orcid":false,"given":"Haydar","family":"Witwit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025112701300836000_2025.11.24.690217v1.1","unstructured":"Sheli R. Radoshitzky ; Michael J. Buchmeier ; Juan Carlos de la Torre Arenaviridae : The Viruses and Their Replication. In Fields Virology: Emerging Viruses, 7e; Knipe, D.M. , Whelan, S.P.J. , Eds.; Lippincott Williams & Wilkins, a Wolters Kluwer business: Philadel-phia, PA, USA, 2021; Vol. 1 ISBN 978-1-9751-1254-7."},{"key":"2025112701300836000_2025.11.24.690217v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03232-y"},{"key":"2025112701300836000_2025.11.24.690217v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00789-8"},{"key":"2025112701300836000_2025.11.24.690217v1.4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000388"},{"key":"2025112701300836000_2025.11.24.690217v1.5","doi-asserted-by":"publisher","DOI":"10.1007\/82_2023_263"},{"key":"2025112701300836000_2025.11.24.690217v1.6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008811"},{"key":"2025112701300836000_2025.11.24.690217v1.7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac266"},{"key":"2025112701300836000_2025.11.24.690217v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00229-9"},{"key":"2025112701300836000_2025.11.24.690217v1.9","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaf308"},{"key":"2025112701300836000_2025.11.24.690217v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.02.020"},{"key":"2025112701300836000_2025.11.24.690217v1.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1863-2378.2012.01469.x"},{"key":"2025112701300836000_2025.11.24.690217v1.12","first-page":"865","article-title":"Emerging Infectious Diseases and Risk to the Traveler","volume":"83","year":"1999","journal-title":"Med. Clin. North Am"},{"key":"2025112701300836000_2025.11.24.690217v1.13","doi-asserted-by":"publisher","DOI":"10.1086\/322620"},{"key":"2025112701300836000_2025.11.24.690217v1.14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2002324118"},{"key":"2025112701300836000_2025.11.24.690217v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33112-3"},{"key":"2025112701300836000_2025.11.24.690217v1.16","unstructured":"Prioritizing Diseases for Research and Development in Emergency Contexts Available online: https:\/\/www.who.int\/activi-ties\/prioritizing-diseases-for-research-and-development-in-emergency-contexts (accessed on 10 March 2025)."},{"key":"2025112701300836000_2025.11.24.690217v1.17","doi-asserted-by":"publisher","DOI":"10.1007\/s40506-015-0058-0"},{"key":"2025112701300836000_2025.11.24.690217v1.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009522"},{"key":"2025112701300836000_2025.11.24.690217v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/srep14775"},{"key":"2025112701300836000_2025.11.24.690217v1.20","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.93.027"},{"key":"2025112701300836000_2025.11.24.690217v1.21","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00951-22"},{"key":"2025112701300836000_2025.11.24.690217v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.an-tiviral.2021.105125"},{"key":"2025112701300836000_2025.11.24.690217v1.23","unstructured":"ARN-75039 | Arenavirus Inhibitor | Probechem Biochemicals Available online: https:\/\/www.probechem.com\/products_ARN-75039.html (accessed on 25 September 2025)."},{"key":"2025112701300836000_2025.11.24.690217v1.24","doi-asserted-by":"publisher","DOI":"10.3201\/eid2409.180233"},{"key":"2025112701300836000_2025.11.24.690217v1.25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10020273"},{"key":"2025112701300836000_2025.11.24.690217v1.26","doi-asserted-by":"crossref","unstructured":"Lukashevich, I.S. ; Paessler, S. ; Torre, J.C. de la Lassa Virus Diversity and Feasibility for Universal Prophylactic Vaccine 2019.","DOI":"10.12688\/f1000research.16989.1"},{"key":"2025112701300836000_2025.11.24.690217v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.020"},{"key":"2025112701300836000_2025.11.24.690217v1.28","doi-asserted-by":"publisher","DOI":"10.15212\/ZOONOSES-2024-0051"},{"key":"2025112701300836000_2025.11.24.690217v1.29","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-018-0604-x"},{"key":"2025112701300836000_2025.11.24.690217v1.30","doi-asserted-by":"crossref","unstructured":"Garry, R.F. Lassa Virus Structural Biology and Replication. In Lassa Fever: Epidemiology, Immunology, Diagnostics, and Therapeutics; Garry, R. , Ed.; Springer International Publishing: Cham, 2023; pp. 147\u2013164 ISBN 978-3-031-35807-4.","DOI":"10.1007\/82_2023_262"},{"key":"2025112701300836000_2025.11.24.690217v1.31","doi-asserted-by":"publisher","DOI":"10.1007\/82_2020_212"},{"key":"2025112701300836000_2025.11.24.690217v1.32","doi-asserted-by":"crossref","unstructured":"Radoshitzky, S.R. ; de la Torre, J.C . Human Pathogenic Arenaviruses (Arenaviridae). In Encyclopedia of Virology; Elsevier, 2019; pp. 507\u2013517 ISBN 978-0-12-814516-6.","DOI":"10.1016\/B978-0-12-814515-9.00014-X"},{"key":"2025112701300836000_2025.11.24.690217v1.33","doi-asserted-by":"crossref","unstructured":"Shao, J. ; Liu, X. ; Liang, Y. ; Ly, H . Assays to Assess Arenaviral Glycoprotein Function. In Hemorrhagic Fever Viruses: Methods and Protocols; Salvato, M.S., Ed.; Springer: New York, NY, 2018; pp. 169\u2013178 ISBN 978-1-4939-6981-4.","DOI":"10.1007\/978-1-4939-6981-4_11"},{"key":"2025112701300836000_2025.11.24.690217v1.34","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.168"},{"key":"2025112701300836000_2025.11.24.690217v1.35","doi-asserted-by":"publisher","DOI":"10.3390\/v17010117"},{"key":"2025112701300836000_2025.11.24.690217v1.36","doi-asserted-by":"crossref","unstructured":"Felciano, R.M. ; Bavari, S. ; Richards, D.R. ; Billaud, J.-N. ; Warren, T. ; Panchal, R. ; Kr\u00e4mer, A . PREDICTIVE SYSTEMS BIOLOGY APPROACH TO BROAD-SPECTRUM, HOST-DIRECTED DRUG TARGET DISCOVERY IN INFECTIOUS DISEASES. In Proceedings of the Biocomputing 2013; WORLD SCIENTIFIC: Kohala Coast, Hawaii, USA, November 2012; pp. 17\u201328.","DOI":"10.1142\/9789814447973_0003"},{"key":"2025112701300836000_2025.11.24.690217v1.37","doi-asserted-by":"publisher","DOI":"10.1021\/ci4005354"},{"key":"2025112701300836000_2025.11.24.690217v1.38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0289890"},{"key":"2025112701300836000_2025.11.24.690217v1.39","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.1c00527"},{"key":"2025112701300836000_2025.11.24.690217v1.40","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.68.1.25-33.1994"},{"key":"2025112701300836000_2025.11.24.690217v1.41","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.69.4.2640-2643.1995"},{"key":"2025112701300836000_2025.11.24.690217v1.42","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.5.1246"},{"key":"2025112701300836000_2025.11.24.690217v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJPATH.2021.04.006\/ATTACHMENT\/9E3E719F-9F70-4B7E-A126-2EBD9B9FE21E\/MMC1.DOCX"},{"key":"2025112701300836000_2025.11.24.690217v1.44","unstructured":"Bennett, C.E. ; Byrd, J.C. ; Elgamal, O.A. ; Goodwin, T.E. ; Hertlein, E. ; Johnson, M.L. ; Tridandapani, S. ; Vibhute, S.M. Methods and Compositions for Inhibition of Dihydroorotate Dehydrogenase in Combination with an Anti-CD38 Therapeutic Agent 2022."},{"key":"2025112701300836000_2025.11.24.690217v1.45","unstructured":"Gudmundsson, K. ; Samano, V. Hcv Inhibitors with Carbazole Structure 2006."},{"key":"2025112701300836000_2025.11.24.690217v1.46","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12680"},{"key":"2025112701300836000_2025.11.24.690217v1.47","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01774-14"},{"key":"2025112701300836000_2025.11.24.690217v1.48","unstructured":"Reversible Disruption of XPO1-Mediated Nuclear Export Inhibits Respiratory Syncytial Virus (RSV) Replication | Scientific Reports Available online: https:\/\/www.nature.com\/articles\/s41598-021-98767-2 (accessed on 3 October 2025)."},{"key":"2025112701300836000_2025.11.24.690217v1.49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167221"},{"key":"2025112701300836000_2025.11.24.690217v1.50","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-26397-7_3"},{"key":"2025112701300836000_2025.11.24.690217v1.51","doi-asserted-by":"publisher","DOI":"10.1038\/srep41660"},{"key":"2025112701300836000_2025.11.24.690217v1.52","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.7b00236"},{"key":"2025112701300836000_2025.11.24.690217v1.53","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02229-10"},{"key":"2025112701300836000_2025.11.24.690217v1.54","first-page":"6","article-title":"[Quantification of Lymphocytic Choriomeningitis Virus with an Immunological Focus Assay in 24 Well Plates] [Article in German]","volume":"10","year":"1993","journal-title":"ALTEX - Altern. Anim. Exp"},{"key":"2025112701300836000_2025.11.24.690217v1.55","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01883-23"},{"key":"2025112701300836000_2025.11.24.690217v1.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.09.008"},{"key":"2025112701300836000_2025.11.24.690217v1.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104667"},{"key":"2025112701300836000_2025.11.24.690217v1.58","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02256-17"},{"key":"2025112701300836000_2025.11.24.690217v1.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2022.01.004"},{"key":"2025112701300836000_2025.11.24.690217v1.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2015.09.001"},{"key":"2025112701300836000_2025.11.24.690217v1.61","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01587-15"},{"key":"2025112701300836000_2025.11.24.690217v1.62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2133782100"},{"key":"2025112701300836000_2025.11.24.690217v1.63","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01012-09"},{"key":"2025112701300836000_2025.11.24.690217v1.64","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01774-14"},{"key":"2025112701300836000_2025.11.24.690217v1.65","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01684-18"},{"key":"2025112701300836000_2025.11.24.690217v1.66","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001891"},{"key":"2025112701300836000_2025.11.24.690217v1.67","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.675112"},{"key":"2025112701300836000_2025.11.24.690217v1.68","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03303-1"},{"key":"2025112701300836000_2025.11.24.690217v1.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105115"},{"key":"2025112701300836000_2025.11.24.690217v1.70","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00155-10"},{"key":"2025112701300836000_2025.11.24.690217v1.71","doi-asserted-by":"publisher","DOI":"10.1086\/657315"},{"key":"2025112701300836000_2025.11.24.690217v1.72","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1468"},{"key":"2025112701300836000_2025.11.24.690217v1.73","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060785"},{"key":"2025112701300836000_2025.11.24.690217v1.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105990"},{"key":"2025112701300836000_2025.11.24.690217v1.75","doi-asserted-by":"publisher","DOI":"10.3390\/microorgan-isms8121872"},{"key":"2025112701300836000_2025.11.24.690217v1.76","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.5c04858"},{"key":"2025112701300836000_2025.11.24.690217v1.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105294"},{"key":"2025112701300836000_2025.11.24.690217v1.78","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-024-03874-8"},{"key":"2025112701300836000_2025.11.24.690217v1.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2021.198388"},{"key":"2025112701300836000_2025.11.24.690217v1.80","unstructured":"Ro 24-7429 Available online: https:\/\/go.drugbank.com\/drugs\/DB16062 (accessed on 3 November 2025)."},{"key":"2025112701300836000_2025.11.24.690217v1.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2008.12.015"},{"key":"2025112701300836000_2025.11.24.690217v1.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2020.05.002"},{"key":"2025112701300836000_2025.11.24.690217v1.83","doi-asserted-by":"publisher","DOI":"10.1016\/j.an-tiviral.2019.104558"},{"key":"2025112701300836000_2025.11.24.690217v1.84","doi-asserted-by":"publisher","DOI":"10.3390\/v12080821"},{"key":"2025112701300836000_2025.11.24.690217v1.85","doi-asserted-by":"publisher","DOI":"10.1371\/jour-nal.pone.0200043"},{"key":"2025112701300836000_2025.11.24.690217v1.86","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.675112"},{"key":"2025112701300836000_2025.11.24.690217v1.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2024.11.002"},{"key":"2025112701300836000_2025.11.24.690217v1.88","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00078-5"},{"key":"2025112701300836000_2025.11.24.690217v1.89","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00168-19"},{"key":"2025112701300836000_2025.11.24.690217v1.90","doi-asserted-by":"publisher","DOI":"10.1038\/srep41660"},{"key":"2025112701300836000_2025.11.24.690217v1.91","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.168"},{"key":"2025112701300836000_2025.11.24.690217v1.92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709113371102"},{"key":"2025112701300836000_2025.11.24.690217v1.93","unstructured":"FDA-Approved HIV Medicines | NIH Available online: https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/fda-approved-hiv-medicines (accessed on 5 November 2025)."},{"key":"2025112701300836000_2025.11.24.690217v1.94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073659"},{"key":"2025112701300836000_2025.11.24.690217v1.95","unstructured":"Treatment of Chronic Hepatitis C Virus Infection in Adults - Clinical Guidelines Program."},{"key":"2025112701300836000_2025.11.24.690217v1.96","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002304"},{"key":"2025112701300836000_2025.11.24.690217v1.97","doi-asserted-by":"publisher","DOI":"10.1038\/nm1777"},{"key":"2025112701300836000_2025.11.24.690217v1.98","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2019.07.006"},{"key":"2025112701300836000_2025.11.24.690217v1.99","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1549"},{"key":"2025112701300836000_2025.11.24.690217v1.100","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00951-22"},{"key":"2025112701300836000_2025.11.24.690217v1.101","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1684"},{"key":"2025112701300836000_2025.11.24.690217v1.102","doi-asserted-by":"publisher","DOI":"10.3390\/v17010092"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.11.24.690217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:05:10Z","timestamp":1768471510000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.11.24.690217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":102,"URL":"https:\/\/doi.org\/10.1101\/2025.11.24.690217","relation":{},"subject":[],"published":{"date-parts":[[2025,11,25]]},"subtype":"preprint"}}